Purpose: to detect phosphoethanolamine (PEtn or PE) in vivo for whole-brain MRSI, overcoming challenges of B1+-inhomogeneities and CSDE at 7T.
Methods: An EPSI-based B1+ robust SLOW-editing was applied to three healthy subjects. TE = 90 ms, TR = 1500 ms, and TA = 9:04 mins.
Results: the editing PE signal at 3.22 ppm was clearly present, and the B1+-homogenous result/map was obtained.
Conclusions: whole-brain in vivo PE-editing can be performed in around 9 minutes measurement time and is therefore clinically applicable.
This abstract and the presentation materials are available to members only; a login is required.